Researchers in low- and middle-income countries are developing their own IP, scaling up local manufacturing, and looking for biomarkers — all in the hope of bringing costs down and getting therapies to people who need them.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnson, B. Reducing the costs of blockbuster gene and cell therapies in the Global South. Nat Biotechnol 42, 8–12 (2024). https://doi.org/10.1038/s41587-023-02049-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-02049-3
- Springer Nature America, Inc.